DarkPulse (DPLS) 10-Q 15 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 15, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-18730
Entity Registrant Name	DarkPulse, Inc.
Entity Central Index Key	0000866439
Entity Tax Identification Number	87-0472109
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	815 Walker Street
Entity Address, Address Line Two	Suite 1155
Entity Address, City or Town	Houston
Entity Address, State or Province	TX
Entity Address, Postal Zip Code	77002
City Area Code	(800)
Local Phone Number	436-1436
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		7,728,834,177

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2023	Dec. 31, 2022
CURRENT ASSETS:
Cash and cash equivalents	$ 64,892	$ 2,060,332
Accounts receivable, net	96,287	2,952,293
Inventory	32,077	23,825
Contract assets	0	1,439,844
Due from related party	948,362	318,025
Prepaid expenses and other current assets	154,414	180,530
TOTAL CURRENT ASSETS	1,296,033	6,974,849
NON-CURRENT ASSETS:
Property and equipment, net	875,173	1,933,871
Operating lease right-of-use assets	1,020,585	2,724,226
Patents, net	229,604	267,875
Notes receivable, related party	1,612,565	1,049,248
Investment in related party	1,500,000	1,500,000
Joint venture	0	46,724
Intangible assets, net	0	390,330
Goodwill	0	6,462,153
Other assets, net	161,678	689,869
TOTAL NON-CURRENT ASSETS	5,399,605	15,064,296
TOTAL ASSETS	6,695,638	22,039,145
CURRENT LIABILITIES:
Accounts payable and accrued expenses	15,627,980	10,736,373
Contract liabilities	0	2,215,212
Loss provision for contracts in progress	0	945,928
Convertible notes, net	334,491	378,263
Notes payable, current	2,000,000	2,000,000
Derivative liability	597,318	306,467
Loan payable, current	468,067	472,700
Loan payable, related party	361,747	361,747
Secured debenture, current	137,406	136,353
Operating lease liabilities - current	213,821	512,373
Other current liabilities	82,568	472,217
TOTAL CURRENT LIABILITIES	19,823,398	18,537,633
NON-CURRENT LIABILITIES:
Secured debenture	961,844	954,474
Loan payable	306,011	328,508
Operating lease liabilities - non-current	907,124	2,547,524
TOTAL NON-CURRENT LIABILITIES	2,174,979	3,830,506
TOTAL LIABILITIES	21,998,376	22,368,139
Commitments and contingencies
STOCKHOLDERS' DEFICIT:
Common stock, par value $0.0001, 20,000,000,000 shares authorized, 7,639,945,289 and 6,427,395,360 shares issued as of September 30, 2023 and December 31, 2022, respectively	763,996	642,740
Treasury stock at cost, 100,000 shares at September 30, 2023 and December 31, 2022	(1,000)	(1,000)
Additional paid-in capital	49,538,461	44,602,052
Non-controlling interests	1,297,589	2,119,566
Accumulated other comprehensive income (loss)	(1,253,370)	(1,137,902)
Accumulated deficit	(65,649,298)	(46,555,334)
TOTAL STOCKHOLDERS' DEFICIT	(15,302,738)	(328,994)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	6,695,638	22,039,145
Series A Preferred Stock [Member]
STOCKHOLDERS' DEFICIT:
Preferred Stock, Value, Issued	1	1
Series D Convertible Preferred Stock [Member]
STOCKHOLDERS' DEFICIT:
Preferred Stock, Value, Issued	$ 883	$ 883

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Preferred stock shares issued	88,335	88,335
Preferred stock shares outstanding	88,335	88,335
Common stock par value	$ 0.0001	$ 0.0001
Common stock shares authorized	20,000,000,000	20,000,000,000
Common stock shares issued	7,639,945,289	6,427,395,360
Treasury stock shares	100,000	100,000
Series A Preferred Stock [Member]
Preferred stock par value	$ 0.01	$ 0.01
Preferred stock shares authorized	100	100
Preferred stock shares issued	100	100
Preferred stock shares outstanding	100	100
Series D Convertible Preferred Stock [Member]
Preferred stock par value	$ 0.01	$ 0.01
Preferred stock shares authorized	100,000	100,000
Preferred stock shares issued	88,235	88,235
Preferred stock shares outstanding	88,235	88,235

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS UNAUDITED - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
REVENUES	$ 82,071	$ 1,431,104	$ 2,032,673	$ 7,884,480
COST OF REVENUES	3,005	5,804,875	2,414,645	12,119,352
GROSS PROFIT (LOSS)	79,066	(4,373,771)	(381,972)	(4,234,872)
OPERATING EXPENSES:
Selling, general and administrative	286,895	1,498,717	1,800,266	3,579,326
Salaries, wages and payroll taxes	253,623	1,760,531	2,379,731	5,108,775
Bad debt expense	11,506	0	2,433,963	0
Professional fees	(40,235)	1,471,264	3,166,153	4,489,966
Depreciation and amortization	44,502	597,970	496,485	833,989
Impairment expense	0	0	6,925,137	0
TOTAL OPERATING EXPENSES	556,290	5,328,482	17,201,734	14,012,056
OPERATING LOSS	(477,224)	(9,702,253)	(17,583,706)	(18,246,928)
OTHER INCOME (EXPENSE):
Interest expense	(123,711)	168,846	(280,774)	(349,758)
Loss on deconsolidation	0	0	(1,642,795)	0
Change in fair market of derivative liabilities	(337,112)	70,289	(320,778)	237,445
Loss on equity investment	(20,764)	0	(159,849)	0
Gain on the forgiveness of debt	0	231,377	106,794	267,127
Restructuring costs	0	0	0	(501,431)
Foreign currency exchange rate variance	(39,765)	426,073	(34,833)	218,039
TOTAL OTHER INCOME (EXPENSE)	(521,352)	896,585	(2,332,234)	(128,578)
Net loss	(998,576)	(8,805,668)	(19,915,940)	(18,375,506)
Net loss attributable to non-controlling interests	11,284	(92,571)	821,977	255,835
Net loss attributable to DarkPulse, Inc.	$ (987,293)	$ (8,898,239)	$ (19,093,964)	$ (18,119,671)

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS UNAUDITED (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net loss per share - basic	$ 0	$ 0	$ 0	$ 0
Net loss per share - diluted	$ 0	$ 0	$ 0	$ 0
Weighted average common shares outstanding - basic	7,564,609,819	5,840,449,453	7,282,672,517	5,539,124,247
Weighted average common shares outstanding - diluted	7,564,609,819	5,840,449,453	7,282,672,517	5,539,124,247

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS UNAUDITED - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
NET LOSS	$ (998,576)	$ (8,805,668)	$ (19,915,940)	$ (18,375,506)
OTHER COMPREHENSIVE INCOME (LOSS)
Foreign currency translation	742,383	(2,694,033)	(115,468)	(2,913,602)
COMPREHENSIVE LOSS	$ (256,193)	$ (11,499,701)	$ (20,031,408)	$ (21,289,108)

CONDSENSED CONSOLIDATED STATEME

CONDSENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY UNAUDITED - USD ($)	Preferred Stock Series A [Member]	Preferred Stock Series D [Member]	Common Stock [Member]	Treasury Stock, Common [Member]	Additional Paid-in Capital [Member]	Noncontrolling Interest [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021		$ 883	$ 519,782	$ (1,000)	$ 20,248,703	$ 2,358,227	$ (284,463)	$ (11,276,490)	$ 11,565,642
Beginning balance, shares at Dec. 31, 2021		88,235	5,197,821,885	100,000
Conversion of convertible notes
Common stock issued for cash			$ 20,012		7,679,988				7,700,000
Common stock issued for cash, shares			200,121,061
Foreign currency adjustment							(219,569)		(219,569)
Net loss								(5,384,270)	(5,384,270)
Ending balance, value at Mar. 31, 2022		$ 883	$ 539,794	$ (1,000)	27,928,691	2,358,227	(504,032)	(16,660,760)	13,661,803
Ending balance, shares at Mar. 31, 2022		88,235	5,397,942,951	100,000
Beginning balance, value at Dec. 31, 2021		$ 883	$ 519,782	$ (1,000)	20,248,703	2,358,227	(284,463)	(11,276,490)	11,565,642
Beginning balance, shares at Dec. 31, 2021		88,235	5,197,821,885	100,000
Net loss									(18,375,506)
Ending balance, value at Sep. 30, 2022		$ 883	$ 614,586	$ (1,000)	44,148,174	2,358,227	(3,198,065)	(29,652,000)	14,270,805
Ending balance, shares at Sep. 30, 2022	100	88,235	6,145,812,186	100,000
Beginning balance, value at Mar. 31, 2022		$ 883	$ 539,794	$ (1,000)	27,928,691	2,358,227	(504,032)	(16,660,760)	13,661,803
Beginning balance, shares at Mar. 31, 2022		88,235	5,397,942,951	100,000
Common stock issued for cash			$ 19,250		4,696,625				4,715,875
Common stock issued for cash, shares			192,448,404
Common stock issued for TerraData acquisition			$ 373		199,627				200,000
Common stock issued for TerraData acquisition, shares			3,725,386
Stock based compensation					(1)
Stock based compensation, shares	100
Foreign currency adjustment							(737,874)		(737,874)
Net loss								(4,185,572)	(4,185,572)
Ending balance, value at Jun. 30, 2022		$ 883	$ 559,417	$ (1,000)	32,824,942	2,358,227	(1,241,906)	(20,846,332)	13,654,232
Ending balance, shares at Jun. 30, 2022	100	88,235	5,594,116,746	100,000
Common stock issued for cash			$ 55,169		11,323,231				11,378,400
Common stock issued for cash, shares			551,695,450
Stock based compensation
Foreign currency adjustment							(1,956,159)		(1,956,159)
Net loss								(8,805,668)	(8,805,668)
Ending balance, value at Sep. 30, 2022		$ 883	$ 614,586	$ (1,000)	44,148,174	2,358,227	(3,198,065)	(29,652,000)	14,270,805
Ending balance, shares at Sep. 30, 2022	100	88,235	6,145,812,186	100,000
Beginning balance, value at Dec. 31, 2022	$ 1	$ 883	$ 642,740	$ (1,000)	44,602,052	2,119,566	(1,137,902)	(46,555,334)	(328,994)
Beginning balance, shares at Dec. 31, 2022	100	88,235	6,427,395,360	100,000
Common stock issued for cash, net of fees			$ 53,167		2,034,634				2,087,801
Common stock issued for cash, net of fees, shares			531,671,500
Issuance of common stock for legal settlement			$ 29,700		1,960,200				1,989,900
Issuance of common stock for legal settlement, shares			297,000,000
Foreign currency adjustment							(462,345)		(462,345)
Net loss						(779,696)		(14,019,568)	(14,799,264)
Ending balance, value at Mar. 31, 2023	$ 1	$ 883	$ 725,607	$ (1,000)	48,596,886	1,339,870	(1,600,247)	(60,574,902)	(11,512,902)
Ending balance, shares at Mar. 31, 2023	100	88,235	7,256,066,860	100,000
Beginning balance, value at Dec. 31, 2022	$ 1	$ 883	$ 642,740	$ (1,000)	44,602,052	2,119,566	(1,137,902)	(46,555,334)	(328,994)
Beginning balance, shares at Dec. 31, 2022	100	88,235	6,427,395,360	100,000
Net loss									(19,915,940)
Ending balance, value at Sep. 30, 2023	$ 1	$ 883	$ 763,996	$ (1,000)	49,538,461	1,297,589	(1,253,370)	(65,649,298)	(15,302,738)
Ending balance, shares at Sep. 30, 2023	100	88,235	7,639,945,289	100,000
Beginning balance, value at Mar. 31, 2023	$ 1	$ 883	$ 725,607	$ (1,000)	48,596,886	1,339,870	(1,600,247)	(60,574,902)	(11,512,902)
Beginning balance, shares at Mar. 31, 2023	100	88,235	7,256,066,860	100,000
Common stock issued for cash			$ 20,384		517,465				537,849
Common stock issued for cash, shares			203,842,371
Foreign currency adjustment							(395,506)		(395,506)
Net loss						(30,997)		(4,087,103)	(4,118,100)
Ending balance, value at Jun. 30, 2023	$ 1	$ 883	$ 745,992	$ (1,000)	49,114,351	1,308,873	(1,995,755)	(64,662,005)	(15,488,659)
Ending balance, shares at Jun. 30, 2023	100	88,235	7,459,909,231	100,000
Common stock issued for cash, net of fees			$ 18,004		424,110				442,114
Common stock issued for cash, net of fees, shares			180,036,058
Foreign currency adjustment							742,383		742,383
Net loss						(11,284)		(987,293)	(998,576)
Ending balance, value at Sep. 30, 2023	$ 1	$ 883	$ 763,996	$ (1,000)	$ 49,538,461	$ 1,297,589	$ (1,253,370)	$ (65,649,298)	$ (15,302,738)
Ending balance, shares at Sep. 30, 2023	100	88,235	7,639,945,289	100,000

CONDENSED CONSOLIDATED STATEM_4

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS UNAUDITED - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities:
Net loss	$ (19,915,940)	$ (18,375,506)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	513,860	833,990
Loss on equity investment	159,849	0
Issuance of common stock for legal settlement	1,989,900	0
Impairment of goodwill and intangible assets	6,925,137	0
Bad debt expense	2,433,876	0
Loss on deconsolidation	1,642,795	0
Operating lease expense	31,087	(33,683)
Gain on forgiveness of debt	(53,397)	(267,127)
Change in fair market of derivative liabilities	(320,778)	(237,445)
Restructuring costs	0	501,431
Changes in operating assets and liabilities:
Accounts receivable	70,870	692,746
Inventory	(8,252)	604,406
Contract assets	(73,048)	178,748
Prepaid expenses and other assets	30,116	(730,370)
Contract liabilities	323,471	833,876
Loss provision for contracts in progress	15,968	(895,405)
Accounts payable and accrued expenses	2,272,852	(2,949,406)
Operating lease liabilities, net	(30,372)	86,511
Other current liabilities	(74,090)	300,533
Net cash used in operating activities	(4,066,096)	(19,456,701)
Cash flows from investing activities:
Purchases of property and equipment	(102,350)	(529,330)
Investment in joint venture	(113,124)	0
Issuance of note receivable, related party	(563,317)	0
Advances to related party	(630,337)	0
Deposits	0	(64,980)
Net cash used in investing activities	(1,409,128)	(594,310)
Cash flows from financing activities:
Proceeds from sale of common stock, net of fees	3,067,764	23,794,275
Proceeds from convertible notes	50,000	0
Net repayments of loan payable	(27,047)	0
Net cash provided by financing activities	3,090,717	23,794,275
Net change in cash	(2,384,507)	3,743,264
Effect of exchange rate on cash	389,067	(1,434,126)
Cash at beginning of period	2,060,332	3,658,846
Cash at end of period	64,892	5,967,984
Supplemental disclosure of cash flow information:
Cash paid for interest	47,948	0
Cash paid for income taxes	0	0
Non-cash financing and investing activities:
Stock issued for acquisition of TerraData	$ 0	$ 200,000

BASIS OF PRESENTATION AND SUMMA

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1 - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Organization and Description of Business DarkPulse, Inc. (“DPI” or “Company”) is a technology-security company incorporated in 1989 as Klever Marketing, Inc. (“Klever”). Its’ wholly-owned subsidiary, DarkPulse Technologies Inc. (“DPTI”), originally started as a technology spinout from the University of New Brunswick, Fredericton, Canada. The Company’s security and monitoring systems will initially be delivered in applications for border security, pipelines, the oil and gas industry and mine safety. Current uses of fiber optic distributed sensor technology have been limited to quasi-static, long-term structural health monitoring due to the time required to obtain the data and its poor precision. The Company’s patented BOTDA dark-pulse sensor technology allows for the monitoring of highly dynamic environments due to its greater resolution and accuracy. The Company’s subsidiaries consisted of Optilan HoldCo 3 Limited, a company headquartered in Coventry, United Kingdom (“Optilan”) whose focus is in telecommunications, energy, rail, critical network infrastructure, pipeline integrity systems, renewables and security; Remote Intelligence, LLC, a company headquartered in Pennsylvania who provides unmanned aerial drone and unmanned ground crawler (UGC) services to a variety of clients from industrial mapping and ecosystem services, to search and rescue, to pipeline security; Wildlife Specialists, LLC, a company headquartered in Pennsylvania who provides clients with comprehensive wildlife and environmental assessment, planning, and monitoring services; TerraData Unmanned, PLLC, a company headquartered in Florida who custom manufactures NDAA compliant drones and unmanned ground crawlers to meet the needs of its customers; and TJM Electronics West, Inc., a company headquartered in Arizona who is a U.S. manufacturer and tester of advanced electronics, cables and sub-assemblies specializing in advanced package and complex CCA and hardware. Liquidation/winding up of Optilan (UK) Limited On May 3, 2023, Eversheds Sutherland (International) LLP, a creditor of Optilan (UK) Limited, filed a petition to wind up (“Winding up Petition”) Optilan (UK) Limited, a wholly owned subsidiary of the Company’s Subsidiary, Optilan HoldCo 3 Limited, and the matter was due to be heard in the Portsmouth Combined Court Centre on June 28, 2023. On June 28, 2023, the High Court of Justice in the United Kingdom issued a winding-up order for the liquidation and winding up of the affairs of Optilan (UK) Limited (“Optilan Liquidation”). In conjunction with the order, the court appointed the Official Receiver’s Office (“OR”) to take the appointment as liquidator of Optilan (UK) Limited and take control of Optilan (UK) Limited’s assets. At the same time the court appointed the OR to take the appointment as liquidator of Optilan (UK) Limited. The OR has taken control of Optilan (UK) Limited’s assets. To date the ORs Office has initiated contact with Optilan but we still wait to receive details of the individual who will be taking the role of OR. On July 3, 2023, Optilan (UK) Limited received a letter from The Insolvency Service, an executive agency sponsored by the Department for Business and Trade located in the U.K. Pursuant to the letter of The Insolvency Services, the Company was required to provide information relating to Optilan (UK) Limited to the Official Receiver’s Office (a government body of Plymouth, the United Kingdom) and attend an interview with staff of the Official Receiver’s Office to review the prospect of recovering the assets of Optilan (UK) Limited for the benefit of creditors. The interview occurred July 18, 2023. The Company is an Unsecured creditor of Optilan (UK) Limited and is at risk of losing any repayment of obligations due from Optilan (UK) Limited because there are several intercompany relationships between the Company and Optilan (UK) Limited, the financial impact of any future claims and liabilities may not be known for several months. The Company has approximately $19.4 million intercompany payables due from Optilan (UK), which will increase the Company liabilities for any obligations not repaid. At the time of this filing the Company is still evaluating the full effects of the winding-up order for liquidation and the material adverse effects it will have on the Company’s continued operations and ability to meet future obligations. On August 9, 2023, Evelyn Partners was appointed Joint Liquidator. Quarter Ended March 31 Accounting Analysis The Company performed an analysis of the trade receivables related to Optilan (UK) Limited and determined that an additional $ 2,422,457 As a result of the Optilan Liquidation, management determined that certain events and circumstances occurred that indicated that the carrying amount of the Company’s reporting unit may not be recoverable as of March 31, 2023. The qualitative assessment was primarily due to the customer contracts held by Optilan (UK) Limited at March 31, 2023 and the associated revenue projections by the UK subsidiary that is subject to the potential winding up. As such, the Company compared the fair value of the reporting unit to the carrying amounts and recorded an impairment loss of $ 6,925,137 356,260 6,568,877 0 Quarter Ended September 30 Accounting Analysis Optilan (UK) Limited became subject to the control of a government and was appointed an administrator. In this situation, when the parent ceases to have a financial interest in a subsidiary and does not retain an investment in that subsidiary, the parent should deconsolidate the subsidiary and recognize a gain or loss on deconsolidation in accordance with ASC 810-10-40-5. In addition, ASC 810-10-40-3A states when a parent deconsolidates a subsidiary or derecognizes a group of assets, the parent no longer controls the subsidiary's assets and liabilities or the group of assets. The parent therefore shall derecognize the assets, liabilities, and equity components related to that subsidiary or group of assets. The equity components will include any noncontrolling interest as well as amounts previously recognized in accumulated other comprehensive income. If the subsidiary or group of assets being deconsolidated or derecognized is a foreign entity (or represents the complete or substantially complete liquidation of the foreign entity in which it resides), then the amount of accumulated other comprehensive income that is reclassified and included in the calculation of gain or loss shall include any foreign currency translation adjustment related to that foreign entity. Upon the liquidation, on June 28, 2023, the Company derecognized Optilan UK’s assets and liabilities and recorded a loss on consolidation of $1,642,795, which was recognized in other income (expenses) in the consolidated statements of operations. Included in the loss on consolidation of $1,642,795 are the gains on intercompany receivables and payables and currency translation adjustment $12,721,532 and $1,545,008 respectively, offset by the net loss of $12,623,745 which is the impairment of investments and intercompany receivables no longer expected to be collected. In addition, the allowance of $2,422,457 was recorded against receivables that have been deemed uncollectible.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the U.S Securities and Exchange Commission for Interim Financial Information. The condensed consolidated financial statements of the Company include the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated. All adjustments (consisting of normal recurring items) necessary to present fairly the Company’s financial position as of September 30, 2023, and the results of operations for nine months and cash flows for the nine months ended September 30, 2023 and 2022 have been included. The Company evaluates its relationships with other entities to identify whether they are variable interest entities (“VIE”) as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation Unaudited Interim Financial Information The accompanying unaudited condensed consolidated balance sheet as of September 30,2023, the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 and of cash flows for the nine months ended September 30, 2023 and 2022 have been prepared by the Company, pursuant to the rules and regulations of the SEC for the interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The unaudited interim consolidated financial statements have been prepared on a basis consistent with the audited consolidated financial statements and in the opinion of management, reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the consolidated results for the interim periods presented and of the consolidated financial condition as of the date of the interim consolidated balance sheet. The results of operations are not necessarily indicative of the results expected for the year ending December 31, 2023. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2022 included in the Company’s Annual Form 10-K filed with SEC on June 23, 2023. Use of Estimates The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, assumptions used to calculate derivative liabilities, revenue recognition and impairment of long-lived assets. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates. Cash The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with high credit quality financial institutions. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. To reduce its risk associated with the failure of such a financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits. Accounts Receivable Accounts receivable and contract assets include amounts billed to customers under the terms and provisions of the contracts. Most billings are determined based on contractual terms. As is common practice in the industry, the Company classifies all accounts receivable and contract assets, including retainage, as current assets. The contracting cycle for certain long-term contracts may extend beyond one year, and accordingly, collection of retainage on those contracts may extend beyond one year. Contract assets include amounts billed to customers under retention provisions in construction contracts. Such provisions are standard in the Company’s industry and usually allow for a portion of progress billings on the contract price, typically 5-10%, to be withheld by the customer until after the Company has completed work on the project. Billings for such retention balances at each balance sheet date are finalized and collected after project completion. Generally, unbilled amounts will be billed and collected within one year. The Company determined that there are no material amounts due past one year and no material amounts billed but not expected to be collected within one year. Also, the Company adopted ASU 2016-13 in January 2023 and the adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures for the period ended September 30, 2023. Each month, the Company reviews its receivables on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived collection issues. Any balances that are eventually deemed uncollectible are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of both September 30, 2023 and December 31, 2022, the Company determined that the allowance for doubtful accounts was $ 0 3,320,983 Accounts receivable includes retainage amounts for the portion of the contract price earned by us for work performed but held for payment by the customer as a form of security until we reach certain construction milestones or complete the project. As of September 30, 2023 and December 31, 2022, retainage receivable was $ 0 824,777 Foreign Currency Translation The Company’s reporting currency is U.S. Dollars. The accounts of one of the Company’s subsidiaries is maintained using the appropriate local currency, British Pound (“GBP”) as the functional currency, as well as the Turkish lira, Emirates Dirham, Azerbajani Manat and Indian Rupee. The accounts of one of the Company’s subsidiaries are maintained using the appropriate local currency, Canadian Dollar (“CAD”) as the functional currency. All assets and liabilities are translated into U.S. Dollars at balance sheet date, shareholders' equity is translated at historical rates and revenue and expense accounts are translated at the average exchange rate for the year or the reporting period. The translation adjustments are reported as a separate component of stockholders’ equity, captioned as accumulated other comprehensive (loss) gain. Transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the statements of operations as foreign currency exchange variance. The relevant translation rates are as follows: for the nine months ended September 30, 2023 closing rate at 1.2197 1.2384 1.3586 The relevant translation rates are as follows: for the nine months ended September 30, 2022 closing rate at 1.113030 1.259161 1.3751 Long-Lived Assets and Goodwill The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets. Indefinite-lived intangible assets established in connection with business combinations consist of the tradename. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company accounts for goodwill and intangible assets in accordance with ASC 350, Intangibles – Goodwill and Other As a result of the Optilan Liquidation as described in Note 1, management determined that certain events and circumstances occurred that indicated that the carrying amount of the Company’s reporting unit may not be recoverable. The qualitative assessment was primarily due to the customer contracts held by Optilan (UK) Limited and the associated revenue projections by the UK subsidiary that is subject to the potential winding up. As such, the Company compared the fair value of the reporting unit to the carrying amounts and recorded an impairment loss of $ 6,925,137 356,260 6,568,877 0 Property and Equipment Property and equipment are carried at historical cost less accumulated depreciation. Depreciation is based on the estimated service lives of the depreciable assets and is calculated using the straight-line method. Expenditures that increase the value or productive capacity of assets are capitalized. Fully depreciated assets are retained in the property and equipment, and accumulated depreciation accounts until they are removed from service. When property and equipment are retired, sold or otherwise disposed of, the asset’s carrying amount and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. Repairs and maintenance are expensed as incurred. The estimated useful lives of property and equipment are generally as follows: Schedule of estimated useful lives Years Office furniture and fixtures 4 Plant and equipment 4-8 Leasehold Improvements 10 Motor vehicles 3 Revenue Recognition The Company’s revenues are generated primarily from the sale of our services, which consist primarily of advanced technology solutions for integrated communications and security systems, as well as habitat management. The Company’s sales of products are primarily generated from our TJM subsidiaries. Sales of products and services are separate from one another. At contract inception, we assess the goods and services promised in the contract with customers and identify a performance obligation for each. To determine the performance obligation, we consider all products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the amount of consideration expected to be received in exchange for transferring goods and services. We recognize service revenues as the performance obligations are met, which is generally as milestones are satisfied over time. We generally recognize product revenues at the time of shipment, provided that all other revenue recognition criteria have been met. The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, we perform the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy a performance obligation. The five-step model is applied to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services transferred to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize revenue in the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. The Company considers each individual sale of service contract to be its own performance obligation. Services in the contract are highly interdependent and interrelated, and the successful completion of each milestone is necessary for the overall success of the contract. Therefore, each milestone is not separately identifiable from other promises in the contract, and not distinct and ultimately not individual performance obligations. The Company records revenue over time using the input measure as it is the most faithful depiction of an entity’s performance because it directly measures the value of the goods and services transferred to the customer. The Company utilizes the Right to Invoice for these contracts, as the pricing structure is based on various milestones that are specified in the contract. These milestones include Construction Phase Plan, Start of the construction phase, installation phase, site surveys, fiber splicing, recoveries, and closeouts. There are specified payments associated with these milestones in the contract, and the value allocated is commensurate with work done. In the event that there are advances such as upfront retainers and not based on the value, those are recorded as contract liabilities. Cost of Revenues Cost of revenues consists primarily of materials and overhead costs incurred internally and amounts incurred to contract manufacturers to produce our products, airtime and other implementation costs incurred to install our products and train customer personnel, and customer service and third-party original equipment manufacturer costs to provide continuing support to our customers. Cost of revenues also includes direct labor attributable to revenue service arrangements. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any losses related to its cash and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships. Leases The Company accounts for its leases under ASC 842, Leases In calculating the right of use asset and lease liability, the Company has elected to combine lease and non-lease components. The Company excludes short-term leases having initial terms of 12 months or less from the new guidance as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term. Fair Value of Financial Instruments The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, Fair Value Measurements and Disclosures. Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The Company’s derivative liability is a Level 3 liability measured at fair value on a recurring basis. See Note 10. Non-controlling Interests Non-controlling interests are classified as a separate component of equity in the Company's consolidated balance sheets and statements of changes in stockholders’ equity. Net income (loss) and comprehensive income (loss) attributable to non-controlling interests are reflected separately from consolidated net income (loss) and comprehensive income (loss) in the consolidated statements of comprehensive income (loss) and statements of changes in stockholders’ equity. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests. In addition, when a subsidiary is deconsolidated, any retained non-controlling equity investment in the former subsidiary will be initially measured at fair value and the difference between the carrying value and fair value of the retained interest will be recorded as a gain or loss. The Company has non-controlling interests via its subsidiaries TerraData, Remote Intelligence and Wildlife Specialists. During the nine months ended September 30, 2023 and 2022, the Company recorded a loss of $ 821,977 255,835 Comprehensive Loss Comprehensive loss includes net loss as well as other changes in stockholders’ equity that result from transactions and economic events other than those with stockholders. During the nine months ended September 30, 2023 and 2022, the Company’s only element of other comprehensive loss was foreign currency translation. Loss Per Common Share The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share Schedule of antidilutive shares September 30, 2023 2022 Convertible notes 302,912,039 87,775,272 Series D preferred stock 176,470 176,470 303,088,509 87,951,742 Recent Accounting Pronouncements In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging Financial Instruments, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief On January 1, 2023, the Company adopted ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASC 326). Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable.

LIQUIDITY AND GOING CONCERN

LIQUIDITY AND GOING CONCERN	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
LIQUIDITY AND GOING CONCERN	NOTE 3 – LIQUIDITY AND GOING CONCERN The Company generated net losses of $ 19,915,940 $ 18,375,506 4,066,096 19,456,701 18,527,365 65,649,298 64,892 The Company will require additional funding during the next twelve months to finance the growth of its current operations and achieve its strategic objectives. These factors, as well as the uncertain conditions that the Company faces relative to capital raising activities, create substantial doubt as to the Company’s ability to continue as a going concern. The Company is seeking to raise additional capital principally through private placement offerings and is targeting strategic partners in an effort to finalize the development of its products and begin generating revenues. The ability of the Company to continue as a going concern is dependent upon the success of future capital offerings or alternative financing arrangements or expansion of its operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary should the Company be unable to continue as a going concern. Management is actively pursuing additional sources of financing sufficient to generate enough cash flow to fund its operations for twelve months from the issuance date of these consolidated financial statements. However, management cannot make any assurances that such financing will be secured.

REVENUE

REVENUE	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
REVENUE	NOTE 4 – REVENUE The following table is a summary of the Company’s timing of revenue recognition for the three and nine months ended September 30, 2023 and 2022: Schedule of timing of revenue recognition Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Services and products transferred at a point in time $ 32,168 $ 463,295 $ 796,716 $ 2,552,462 Services and products transferred over time 49,903 967,809 1,235,957 5,332,018 Total revenue $ 82,071 $ 1,431,104 $ 2,032,673 $ 7,884,480 The Company disaggregates revenue by source and geographic destination to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. Revenue by source consisted of the following for the three and nine months ended September 30, 2023 and 2022: Schedule of revenue by source Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Products $ 71,886 $ 136,534 $ 329,400 $ 1,246,610 Services 10,185 1,294,570 1,703,273 6,637,870 Total revenue $ 82,071 $ 1,431,104 $ 2,032,673 $ 7,884,480 Revenue by geographic destination consisted of the following for the three and nine months ended September 30, 2023 and 2022: Schedule of revenue by geographic destination Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 North America $ 74,586 $ 590,028 $ 449,238 $ 1,124,462 United Kingdom 7,485 – 1,397,152 – Rest of world – 841,076 186,283 6,760,018 Total revenue $ 82,071 $ 1,431,104 $ 2,032,673 $ 7,884,480 Contracts Contract revenue is recognized over time using the cost-to-cost measure of progress for fixed price contracts. The cost-to-cost measure of progress best depicts the continuous transfer of control of goods or services to the customer. The contractual terms provide that the customer compensates the Company for services rendered. Contract costs include all direct materials, labor and subcontracted costs, as well as indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs and the costs of capital equipment. The cost estimation and review process for recognizing revenue over time under the cost-to-cost method is based on the professional knowledge and experience of the Company’s project managers, engineers and financial professionals. Management reviews estimates of total contract transaction price and total project costs on an ongoing basis. Changes in job performance, job conditions and management’s assessment of expected variable consideration are factors that influence estimates of the total contract transaction price, total costs to complete those contracts and profit recognition. Changes in these factors could result in revisions to revenue and costs of revenue in the period in which the revisions are determined on a prospective basis, which could materially affect the Company’s consolidated results of operations for that period. Provisions for losses on uncompleted contracts are recorded in the period in which such losses are determined. Performance Obligations A performance obligation is a contractual promise to transfer a distinct good or service to the customer and is the unit of account under Accounting Standards Codification (“ASC”) Topic 606. The transaction price of a contract is allocated to distinct performance obligations and recognized as revenue when or as the performance obligations are satisfied. The Company’s contracts often require significant integrated services and, even when delivering multiple distinct services, are generally accounted for as a single performance obligation. Contract amendments and change orders are generally not distinct from the existing contract due to the significant integrated service provided in the context of the contract and are accounted for as a modification of the existing contract and performance obligation. The majority of the Company’s performance obligations are completed within one year. When more than one contract is entered into with a customer on or close to the same date, the Company evaluates whether those contracts should be combined and accounted for as a single contract as well as whether those contracts should be accounted for as more than one performance obligation. This evaluation requires significant judgment and is based on the facts and circumstances of the various contracts, which could change the amount of revenue and profit recognition in a given period depending upon the outcome of the evaluation. Contract Assets and Liabilities The Company bill its customers based on contractual terms, including, milestone billings based on the completion of certain phases of the work. Sometimes, billing occurs after revenue recognition, resulting in unbilled revenue, which is accounted for as a contract asset. Sometimes the Company receives advances payments from our customers before revenue is recognized, resulting in deferred revenue, which is accounted for as a contract liability. Contract assets in the consolidated balance sheets represents costs and estimated earnings in excess of billings, which arise when revenue has been recorded but the amount has not been billed. As of September 30, 2023, contract assets were $0 upon derecognized pursuant to the Optilan Liquidation. Contract liabilities on September 30, 2023 are $0 upon the deconsolidation related to the Optilan liquidation. Variable Consideration Transaction pricing for the Company’s contracts may include variable consideration, such as unapproved change orders, claims, incentives and liquidated damages. Management estimates variable consideration for a performance obligation utilizing estimation methods that best predict the amount of consideration to which the Company will be entitled. Variable consideration is included in the estimated transaction price to the extent it is probable that a significant reversal of cumulative revenue recognized will not occur when the uncertainty associated with the variable consideration is resolved. Management’s estimates of variable consideration and determination of whether to include estimated amounts in transaction price are based on past practices with the customer, specific discussions, correspondence or preliminary negotiations with the customer, legal evaluations and all other relevant information that is reasonably available. The effect of a change in variable consideration on the transaction price of a performance obligation is typically recognized as an adjustment to revenue on a cumulative catch-up basis. To the extent unapproved change orders, claims and liquidated damages reflected in transaction price are not resolved in the Company’s favor, or to the extent incentives reflected in transaction price are not earned, there could be reductions in, or reversals of, previously recognized revenue.

ACCOUNTS RECEIVABLE

ACCOUNTS RECEIVABLE	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
ACCOUNTS RECEIVABLE	NOTE 5 – ACCOUNTS RECEIVABLE Accounts receivable consisted of the following as of September 30, 2023 and December 31, 2022: Schedule of accounts receivable September 30, December 31, 2023 2022 Accounts receivable $ 96,287 $ 6,273,276 Less: Allowance for doubtful accounts – (3,320,983 ) Accounts receivable, net $ 96,287 $ 2,952,293

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 6 – PROPERTY AND EQUIPMENT Property and equipment consisted of the following as of September : Schedule of property and equipment September 30, December 31, 2023 2022 Property and equipment $ 1,300,521 $ 3,942,421 Leasehold improvements 46,934 46,934 Property and equipment at cost 1,347,455 3,989,355 Less - accumulated depreciation (472,282 ) (2,055,484 ) Property and equipment, net $ 875,173 $ 1,933,871

GOODWILL AND OTHER INTANGIBLE A

GOODWILL AND OTHER INTANGIBLE ASSETS	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
GOODWILL AND OTHER INTANGIBLE ASSETS	NOTE 7 – GOODWILL AND OTHER INTANGIBLE ASSETS Goodwill The following is a summary of activity of goodwill for the nine months ended September 30, 2023: Schedule of changes in carrying amount of goodwill Goodwill Balances at December 31, 2022 $ 6,462,153 Impairment of goodwill pertaining to Optilan (6,568,877 ) Foreign exchange translation 106,724 Balances at September 30, 2023 $ – Intangible Assets, Net On January 1, 2023, the Company revised the estimated useful life of the trade name intangible asset from 25 10 34,225 38,271 During the three months ended March 31, 2023, the Company recorded impairment of the trade name of $ 356,260 0 390,330 Patents - Intrusion Detection Intellectual Property The following is a summary of the DPTI patents: Schedule of patents September 30, December 31, 2023 2022 Patents $ 904,269 $ 904,269 Less: accumulated amortization (674,665 ) (636,394 ) Patents, net $ 229,604 $ 267,875 For the nine months ended September 30, 2023 and 2022, the Company amortized $ 38,271 38,271

JOINT VENTURE

JOINT VENTURE	9 Months Ended
	Sep. 30, 2023
Equity Method Investments and Joint Ventures [Abstract]
JOINT VENTURE	NOTE 8 – JOINT VENTURE On September 9, 2022, the Company entered into a Joint Venture Agreement with Neural Signals Inc, (“NSI”), for the purpose of developing, marketing and selling products and services based on the patents issued to NSI. The parties established the Joint Venture, Neural Logistics Inc., under a separate entity to conduct business. The Company has 50 During the nine months ended September 30, 2023, the Company contributed $ 113,124 159,849

ACCOUNTS PAYABLE AND ACCRUED EX

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED EXPENSES	NOTE 9 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES Accounts payable and accrued expenses consisted of the following as of September 30, 2023 and December 31, 2022: Schedule of accounts payable and accrued expenses September 30, December 31, 2023 2022 Accounts payable $ 14,108,937 $ 8,677,648 Accrued liabilities 1,519,043 2,058,725 Total accounts payable and accrued expenses $ 15,627,980 $ 10,736,373

DEBT

DEBT	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
DEBT	NOTE 10 – DEBT Convertible Notes As of September 30, 2023 and December 31, 2022, there was $ 334,491 378,263 As of September 30, 2023 and December 31, 2022 there was a derivative liability of $ 597,318 306,467 On August 7, 2023, the Company entered into a convertible note for a principal of $ 57,750 10 39 On September 29, 2023, the Company entered into a convertible note for a principal of $ 57,750 (see Note 16). As of September 30, 2023, all outstanding convertible debt is in default The following is a summary of convertible notes: Schedule of convertible notes September 30, 2023 December 31, 2022 Principal outstanding $ 382,616 $ 378,263 Less: unamortized debt discount (48,125 ) – Convertible notes, net $ 334,491 $ 378,263 During the nine months ended September 30, 2023 and 2022, $ 9,625 0 Notes Payable On July 14, 2021, the Company entered a Securities Purchase Agreement (the “ GS SPA 2,000,000 GS Note July 14, 2022 6 2,000,000 Loans Payable The Company’s RI and WS subsidiaries have various loans including Small Business Association (“SBA”) Economic Injury Disaster Loan (“EIDL”) loans, lines of credit and other advances. The loans bear interest with varying rates up to 9.25% per annum. The following is a summary of the loans payable at September 30, 2023 and December 31, 2022: Schedule of loans payable September 30, December 31, 2023 2022 RI - line of credit $ 99,971 $ 99,971 RI - Short-term loans 41,279 43,899 WS - line of credit 200,000 200,000 WS- Short-term loans 126,817 128,830 Loan payable, current $ 468,067 $ 472,700 RI - SBA EIDL $ 102,597 $ 102,597 RI - long-term loans 84,661 86,041 WS - SBA EIDL 26,307 26,307 WS - long-term loans 92,446 113,564 Loan payable, non-current $ 306,011 $ 328,508

SECURED DEBENTURE

SECURED DEBENTURE	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
SECURED DEBENTURE	NOTE 11 – SECURED DEBENTURE DPTI issued a convertible Debenture to the University (see Note 1) in exchange for the Patents assigned to the Company, in the amount of Canadian $1,500,000, or US$1,491,923 on December 16, 2010, the date of the Debenture. On April 24, 2017 DPTI issued a replacement secured term Debenture in the same CAD 1,500,000 amount as the original Debenture. The interest rate is the Bank of Canada Prime overnight rate plus 1% per annum. The Debenture had an initial required payment of CAD 42,000 (US$33,385) due on April 24, 2018 for reimbursement to the University of its research and development costs, and this has been paid. Interest-only maintenance payments are due annually starting after April 24, 2018. Payment of the principal begins on the earlier of (a) three years following two consecutive quarters of positive earnings before interest, taxes, depreciation and amortization, (b) six years from April 24, 2017, or (c) in the event DPTI fails to raise defined capital amounts or secure defined contract amounts by April 24 in the years 2018, 2019, and 2020. The Company has raised funds in excess of the amount required for 2020, 2019 and 2018. The principal repayment amounts will be due quarterly over a six year period in the amount of Canadian Dollars 62,500. Based on the exchange rate between the Canadian Dollar and the U.S. Dollar on December 31, 2018, the quarterly principal repayment amounts will be US$48,447. The Debenture is secured by the Patents assigned by the University to DPTI by an Assignment Agreement on December 16, 2010. DPTI has pledged the Patents, and granted a lien on them pursuant to an Escrow Agreement dated April 24, 2017, between DPTI and the University. The Debenture was initially recorded at the $1,491,923 equivalent U.S. Dollar amount of Canadian 1,500,000 as of December 16, 2010, the date of the original Debenture. The liability is being adjusted quarterly based on the current exchange value of the Canadian dollar to the U.S. dollar at the end of each quarter. The adjustment is recorded as unrealized gain or loss in the change of the value of the two currencies during the quarter. The Debenture also includes a provision requiring DPTI to pay the University a 2% royalty on sales of any and all products or services which incorporate the Patents for a period of five years from April 24, 2018. To date, no royalties have been paid. The payments are current at the present time. For the nine months ended September 30, 2023, and 2022, the Company recorded interest expense of $ 19,401 36,307 As of September 30, 2023 and December 31, 2022, the debenture liability totaled $ 1,099,250 1,090,827

LEASES

LEASES	9 Months Ended
	Sep. 30, 2023
Leases
LEASES	NOTE 12 – LEASES The following was included in our balance sheet as of September 30, 2023 and December 31, 2022: Schedule of operating leases September 30, December 31, Operating leases 2023 2022 Assets ROU operating lease assets $ 1,020,585 $ 2,724,226 Liabilities Current portion of operating lease 213,821 512,373 Operating lease, net of current portion 907,124 2,547,524 Total operating lease liabilities $ 1,120,945 $ 3,059,897 The weighted average remaining lease term and weighted average discount rate at September 30, 2023 and December 31, 2022 were as follows: Schedule of weighted average remaining lease term and weighted average discount rate September 30, December 31, Operating leases 2023 2022 Weighted average remaining lease term (years) 7.75 8.25 Weighted average discount rate 6.00 6.00 Operating Leases On January 12, 2021, the Company’s newly acquired subsidiary entered into an operating lease agreement to rent office space in Mumbai, India. This three-year agreement commenced January 12, 2021 with an annual rent of approximately $ 50,000 On May 27, 2021, the Company’s newly acquired subsidiary entered into an operating lease agreement to rent office space in Warwick, United Kingdom. This ten-year agreement commenced May 27, 2021 with an annual rent of approximately $ 85,000 On August 31, 2021, the Company’s newly acquired subsidiary entered into an operating lease agreement to rent office space in Tempe, Arizona. This five-year agreement commenced August 31, 2021 with an annual rent of approximately $ 192,000 On October 20, 2021, the Company’s newly acquired subsidiary entered into an operating lease agreement to rent office space in Warwick, United Kingdom. This ten-year agreement commenced October 20, 2021 with an annual rent of approximately $ 200,000 On March 9, 2022, the Company entered into an operating lease agreement to rent office space in Houston, Texas. This ten-year agreement commenced March 9. 2022 with an annual rent of approximately $ 81,000 On June 28, 2023, the Company recognized a gain on deconsolidation of $1,775,869 related to Optilan (UK) and its subsidiaries leases.

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT)	9 Months Ended
	Sep. 30, 2023
STOCKHOLDERS' DEFICIT:
STOCKHOLDERS' EQUITY (DEFICIT)	NOTE 13 - STOCKHOLDERS' EQUITY (DEFICIT) Preferred Stock In accordance with the Company’s Certificate of Incorporation, the Company has authorized a total of 2,000,000 0.01 88,335 88,335 Common Stock In accordance with the Company’s Certificate of Incorporation, the Company has authorized a total of 20,000,000,000 0.0001 7,639,945,289 6,427,395,360 7,639,845,289 6,427,295,360 2023 Transactions On May 27, 2022, we entered an Equity Financing Agreement (the “ 2022 EFA RRA Registration Statement On April 28, 2023 the Company entered into an Equity Financing Agreement with GHS, to which GHS agreed to Purchase $30,000,000 in shares of our Common Stock over the course of 12 months at 92% of the current market price. On June 13, 2023 the Company entered into an Amendment to the 2023 Equity Financing Agreement with GHS, to which GHS agreed to Purchase $30,000,000 in shares of our Common Stock over the course of 12 months at 92% of the current market price. On July 10,2023 the Company entered into a Second Amendment to the 2023 Equity Financing Agreement with GHS, to which GHS agreed to purchase up to $30,000,000 in shares of our Common Stock over the course of 12 months at 92% of the current market price. On September 5, 2023, we entered into a Stock Purchase Agreement with an investor for the purchase of 100,000,000 shares of Common Stock for a total consideration of $100,000. The RRA provides that we shall (i) use our best efforts to file with the SEC a Registration Statement within 45 days of the date of the GHS Registration Rights Agreement; and (ii) have the Registration Statement declared effective by the SEC within 30 days after the date the GHS Registration Statement is filed with the SEC, but in no event more than 90 days after the GHS Registration Statement is filed. The below table of puts from 1/12/2023 through 4/11/2023 were made by the Company under the 2022 EFA during 2023. The put from 4/28/2023 was made under the EFA dated 4/28/2023. The puts from 6/26/2023 and 7/3/2023 were made by the Company under the Amended EFA dated June 13, 2023. The 7/10/2023 put was made by the Company under the Second Amended EFA dated July 10, 2023. Schedule of equity financing agreement Date of Put Number of Common Shares Issued Total Proceeds, Net of Discounts Effective Price per Share Net Proceeds 1/12/2023 64,130,435 $ 400,000 $0.006237 $ 370,975 1/17/2023 11,441,647 100,000 $0.008740 100,000 1/24/2023 77,733,861 400,000 $0.005146 370,975 2/3/2023 61,173,706 300,000 $0.004904 277,975 2/17/2023 75,447,571 300,000 $0.003976 277,975 3/1/2023 83,113,044 324,000 $0.003898 300,295 3/16/2023 93,165,852 254,232 $0.002729 235,410 3/30/2023 65,465,384 166,903 $0.002549 154,195 4/11/2023 67,462,162 203,553 $0.003017 188,280 4/28/2023 91,796,875 235,000 $0.002560 208,550 6/26/2023 44,583,334 214,000 $0.004800 141,020 7/3/2023 51,442,308 274,058 $0.004200 257,020 7/10/2023 28,593,750 91,500 $0.003200 85,094 9/5/2023 100,000,000 100,000 $0.001000 100,000 915,549,929 $ 3,363,246 $ 3,067,764 In January 2023, the Company entered into a settlement of a dispute between certain stockholders in which the Company decided, during the period ended June 30, 2023, to issue shares to settle the dispute. In January 2023, the Company issued 297,000,000 1,989,900 0.0067

COMMITMENTS & CONTINGENCIES

COMMITMENTS & CONTINGENCIES	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS & CONTINGENCIES	NOTE 14 - COMMITMENTS & CONTINGENCIES Potential Royalty Payments The Company, in consideration of the terms of the debenture to the University of New Brunswick, shall pay to the University a two percent royalty on sales of any and all products or services, which incorporate the Company's patents for a period of five years from April 24, 2018. Legal Matters DarkPulse, Inc. v. Twitter, Inc. As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company is actively investigating potential claims against the MIKEWOOD and BullMeechum3 Twitter accounts. There are no material updates to this matter. Carebourn Capital, L.P. v. DarkPulse, Inc. As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company remains in active litigation with Carebourn Capital, L.P. (“Carebourn”) in Minnesota state court. The following discloses the material updates for this matter. On August 22, 2023, the Minnesota state held oral arguments on the Company’s motion for summary judgment on its counterclaims, which seek an award of damages in the amount of $124,012.91 (excluding pre- and post-judgment interest), attorneys’ fees in the amount of $267,951.33, and costs in the amount of $50,785.50. The Company is currently awaiting a decision on its motion for summary judgment. More Capital, LLC v. DarkPulse, Inc. et al As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company remains in active litigation with More Capital, LLC (“More”) in Minnesota state court. The following discloses the material updates for this matter. On August 22, 2023, the Minnesota state held oral arguments on the Company’s motion for summary judgment on its motion for summary judgment on its affirmative defenses and counterclaims, the latter of which seek an award of damages in the amount of $300,809.39 (excluding pre- and post-judgment interest), attorneys’ fees in the amount of $111,019.00, and costs in the amount of $195.75. The Company is currently awaiting a decision on its motion for summary judgment. Carebourn Capital et al v. Standard Registrar and Transfer et al As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company remains in active litigation with Carebourn Capital, L.P. (“Carebourn”) and More Capital, LLC (“More,” and together with Carebourn, the “Noteholders”) in the United States District Court for the District of Utah. The following discloses the material updates for this matter. On September 27, 2023, the U.S. Securities and Exchange Commission (“SEC”) prevailed on its motion for summary judgment against Carebourn that sought declaratory judgment that Carebourn is an unregistered dealer acting in violation of Section 15(a) of the Securities Exchange Act of 1934. On November 1, 2023, the Noteholders filed a motion to dismiss this litigation with prejudice (the “Dismissal Motion”). On November 2, 2023, the Company filed a cross-motion to the Dismissal Motion, wherein the Company did not oppose the Noteholders’ request for dismissal with prejudice and cross-moved for sanctions against the Noteholders and their attorneys of record. The Noteholders’ opposition thereto is due on or before November 16, 2023. The Company maintains that the Noteholder’s lawsuit is duplicative of the first-filed lawsuits commenced by the Noteholder’s in Minnesota state court. The Company intends to vigorously defend itself against the Noteholder’s Utah lawsuit. Goodman et al. v. DarkPulse, Inc. As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company settled a dispute with Stephen Goodman, Mark Banash, and David Singer. Accordingly, there are no material updates for this matter. DarkPulse, Inc. v. FirstFire Global Opportunities Fund, LLC, and Eli Fireman As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company remains in active litigation with FirstFire Global Opportunities Fund, LLC (“FirstFire”), and Eli Fireman (“Fireman”) (FirstFire and Fireman together, the “FirstFire Parties”). The following discloses the material updates for this matter. On September 12, 2023, the United States Court of Appeals for the Second Circuit (“Second Circuit”) calendared oral arguments for the appeal—which challenges United States District Court for the Southern District of New York’s granting the FirstFire Parties’ motion to dismiss—for the week of December 11, 2023. On October 12, 2023, the Second Circuit scheduled oral arguments for the appeal on December 13, 2023. The Company remains committed to actively litigating its claims for relief under the Securities Exchange Act of 1934 and Racketeer Influenced and Corrupt Organizations Act. DarkPulse, Inc. v. EMA Financial, LLC et al As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company settled a dispute with EMA Financial, LLC (“EMA”), EMA Group, Inc. (“EMA Group”), and Felicia Preston (“Preston”) (EMA, EMA Group, and Preston together, the “EMA Parties”). Accordingly, there are no material updates for this matter. DarkPulse, Inc. v. Brunson Chandler & Jones, PLLC et al As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company remains in active litigation with Brunson Chandler & Jones, PLLC (“Brunson Firm”), and Lance B. Brunson (“Brunson,” and together with the Brunson Firm, the “Brunson Parties”). The Company remains committed to litigating its claims and affirmative defenses against the Brunson Parties. DarkPulse, Inc., et al v. Crown Bridge Partners, LLC, et al As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company—alongside two other plaintiffs, Social Life Network, Inc. and Redhawk Holdings Corp. —remains in active litigation with Crown Bridge Partners, LLC, Soheil Ahdoot, and Sepas Ahdoot (“Crown Bridge Defendants”). The following discloses the material updates for this matter. On September 29, 2023, the United States District Court for the Southern District of New York granted the Crown Bridge Defendants’ motion to dismiss. On October 24, 2023, the Company, alongside Social Life Network, Inc. and RedHawk Holdings Corp., appealed the district court’s decision to the United States Court of Appeals for the Second Circuit. Briefing has not yet been scheduled for this appeal. The Company remains committed to actively litigating its Racketeer Influenced and Corrupt Organizations Act claims against the Crown Bridge Defendants. Benner et al v. DarkPulse, Inc. et al As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company and its CEO, Dennis O’Leary (together with the Company, the “DPLS Defendants”), remain in active litigation with J. Merlin Benner, Phillip J. Benner, Benjamin P. Benner, Jonas M. Benner, and Angelica M. Benner (collectively, the “Benner Parties”) in the United States District Court for the Southern District of Texas. The following discloses the material updates for this matter. On June 30, 2023, the DPLS Defendants filed their answer to the Benner Parties’ complaint, wherein they interposed numerous affirmative defenses. The parties have since began conducting discovery in this matter. The Company remains committed to actively litigating its affirmative defenses to the Benner Parties’ claims. GS Capital Partners, LLC v. DarkPulse, Inc. As disclosed in greater detail in the Company’s Form 10-Q, filed September 22, 2023, the Company was sued by GS Capital Partners, LLC (“GS Capital”) in the Supreme Court for New York County. The following discloses the material updates for this matter. On or about September 27, 2023, the Company and GS Capital confidentially settled the dispute. On or about October 3, 2023, the parties filed a stipulation with the court to vacate the judgment entered against the Company and in favor of GS Capital, vacate the motion filed by the Company, and discontinue the action. On or about October 9, 2023, the court vacated the judgment. The parties are currently waiting for the court to dismiss the action. From time to time, we may become involved in litigation relating to claims arising out of our operations in the normal course of business. We are not currently involved in any pending legal proceeding or litigation and, to the best of our knowledge, no governmental authority is contemplating any proceeding to which we are a party or to which any of our properties is subject, which would reasonably be likely to have a material adverse effect on our business, financial condition and operating results.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 15 – RELATED PARTY TRANSACTIONS The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions. Pursuant to Section 850-10-20 the related parties include a) affiliates of the Company; b) Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. The financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement. During the nine months ended September 30, 2023 and 2022, certain executives of the Company received 120,000 0 Remote Intelligence and Wildlife Specialists Loan Payables RI has a loan payable with the former majority shareholder, who is a shareholder in the Company after the acquisition of 60% of RI’s membership interests. The loan is unsecured, non-interest bearing and due on demand. As of both September 30, 2023 and December 31, 2022, the outstanding balance was $ 226,247 WS has a loan payable with the former majority shareholder, who is a shareholder in the Company after the acquisition of 60% of WS’s membership interests. The loan is unsecured, non-interest bearing and due on demand. As of both September 30, 2023 and December 31, 2022, the outstanding balance was $ 135,500 SPAC Transaction On October 12, 2022, the Company entered into and closed the Purchase Agreement (the “Agreement”) pursuant to which the Company purchased 2,623,120 4,298,496 1,500,000 As of September 30, 2023 and December 31, 2022, the Company’s $ 1,500,000 In addition to the payment of the Purchase Price, the Company also assumed the following obligations: (i) responsibility for all of SPAC’s public company reporting obligations, (ii) the right to provide an extension payment and extend the deadline of the SPAC to complete an initial business combination from 15 months from August 9, 2021 to 18 months for an additional $1,150,000, and (iii) all other obligations and liabilities of the Original Sponsor related to the SPAC. The principal balance of this note shall be payable by GSD on the earlier to occur of: (i) the date on which GSD consummates its initial business combination (the “Business Combination”) and (ii) the date that the winding up of GSD is effective. The note does not bear interest. On February 7, 2023 and March 9, 2023, GSD issued a non-convertible promissory note in the aggregate principal amount of $ 167,894 1,612,565 1,049,248 As of September 30, 2023 and December 31, 2022, the Company has $ 948,362 318,025

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 16 – SUBSEQUENT EVENTS Subsequent to period end, the Company issued 88,888,888 shares to a third party in exchange for cash in accordance with its equity agreement. On September 29, 2023, the Company entered into a convertible note for a principal of $57,750, which was funded on October 4, 2023. The note bears interest at a rate of 10% per annum and matures after one year. Following 180 days from the note, the noteholder may convert at a discount of 39%. The Company has reserved a sufficient number of shares of common stock for issuance upon full conversion of the note in accordance with the terms

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The consolidated financial statements and accompanying notes are prepared in accordance with generally accepted accounting principles of the United States of America (“U.S. GAAP”) and the rules and regulations of the U.S Securities and Exchange Commission for Interim Financial Information. The condensed consolidated financial statements of the Company include the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated. All adjustments (consisting of normal recurring items) necessary to present fairly the Company’s financial position as of September 30, 2023, and the results of operations for nine months and cash flows for the nine months ended September 30, 2023 and 2022 have been included. The Company evaluates its relationships with other entities to identify whether they are variable interest entities (“VIE”) as defined by Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 810, Consolidation
Unaudited Interim Financial Information	Unaudited Interim Financial Information The accompanying unaudited condensed consolidated balance sheet as of September 30,2023, the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2023 and 2022 and of cash flows for the nine months ended September 30, 2023 and 2022 have been prepared by the Company, pursuant to the rules and regulations of the SEC for the interim financial statements. Certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to rules and regulations. However, the Company believes that the disclosures are adequate to make the information presented not misleading. The unaudited interim consolidated financial statements have been prepared on a basis consistent with the audited consolidated financial statements and in the opinion of management, reflect all adjustments, consisting of only normal recurring adjustments, necessary for the fair presentation of the consolidated results for the interim periods presented and of the consolidated financial condition as of the date of the interim consolidated balance sheet. The results of operations are not necessarily indicative of the results expected for the year ending December 31, 2023. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the year ended December 31, 2022 included in the Company’s Annual Form 10-K filed with SEC on June 23, 2023.
Use of Estimates	Use of Estimates The preparation of the Company’s financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Significant estimates and assumptions reflected in these financial statements include, but are not limited to, assumptions used to calculate derivative liabilities, revenue recognition and impairment of long-lived assets. The Company bases its estimates on historical experience, known trends and other market-specific or other relevant factors that it believes to be reasonable under the circumstances. On an ongoing basis, management evaluates its estimates when there are changes in circumstances, facts and experience. Changes in estimates are recorded in the period in which they become known. Actual results could differ from those estimates.
Cash	Cash The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with high credit quality financial institutions. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. To reduce its risk associated with the failure of such a financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.
Accounts Receivable	Accounts Receivable Accounts receivable and contract assets include amounts billed to customers under the terms and provisions of the contracts. Most billings are determined based on contractual terms. As is common practice in the industry, the Company classifies all accounts receivable and contract assets, including retainage, as current assets. The contracting cycle for certain long-term contracts may extend beyond one year, and accordingly, collection of retainage on those contracts may extend beyond one year. Contract assets include amounts billed to customers under retention provisions in construction contracts. Such provisions are standard in the Company’s industry and usually allow for a portion of progress billings on the contract price, typically 5-10%, to be withheld by the customer until after the Company has completed work on the project. Billings for such retention balances at each balance sheet date are finalized and collected after project completion. Generally, unbilled amounts will be billed and collected within one year. The Company determined that there are no material amounts due past one year and no material amounts billed but not expected to be collected within one year. Also, the Company adopted ASU 2016-13 in January 2023 and the adoption did not have a material impact on the Company’s condensed consolidated financial statements and related disclosures for the period ended September 30, 2023. Each month, the Company reviews its receivables on a customer-by-customer basis and evaluates whether an allowance for doubtful accounts is necessary based on any known or perceived collection issues. Any balances that are eventually deemed uncollectible are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of both September 30, 2023 and December 31, 2022, the Company determined that the allowance for doubtful accounts was $ 0 3,320,983 Accounts receivable includes retainage amounts for the portion of the contract price earned by us for work performed but held for payment by the customer as a form of security until we reach certain construction milestones or complete the project. As of September 30, 2023 and December 31, 2022, retainage receivable was $ 0 824,777
Foreign Currency Translation	Foreign Currency Translation The Company’s reporting currency is U.S. Dollars. The accounts of one of the Company’s subsidiaries is maintained using the appropriate local currency, British Pound (“GBP”) as the functional currency, as well as the Turkish lira, Emirates Dirham, Azerbajani Manat and Indian Rupee. The accounts of one of the Company’s subsidiaries are maintained using the appropriate local currency, Canadian Dollar (“CAD”) as the functional currency. All assets and liabilities are translated into U.S. Dollars at balance sheet date, shareholders' equity is translated at historical rates and revenue and expense accounts are translated at the average exchange rate for the year or the reporting period. The translation adjustments are reported as a separate component of stockholders’ equity, captioned as accumulated other comprehensive (loss) gain. Transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the statements of operations as foreign currency exchange variance. The relevant translation rates are as follows: for the nine months ended September 30, 2023 closing rate at 1.2197 1.2384 1.3586 The relevant translation rates are as follows: for the nine months ended September 30, 2022 closing rate at 1.113030 1.259161 1.3751
Long-Lived Assets and Goodwill	Long-Lived Assets and Goodwill The Company accounts for long-lived assets in accordance with the provisions of ASC 360-10-35, Property, Plant and Equipment, Impairment or Disposal of Long-lived Assets. Indefinite-lived intangible assets established in connection with business combinations consist of the tradename. The impairment test for identifiable indefinite-lived intangible assets consists of a comparison of the estimated fair value of the intangible asset with its carrying value. If the carrying value exceeds its fair value, an impairment loss is recognized in an amount equal to that excess. The Company accounts for goodwill and intangible assets in accordance with ASC 350, Intangibles – Goodwill and Other As a result of the Optilan Liquidation as described in Note 1, management determined that certain events and circumstances occurred that indicated that the carrying amount of the Company’s reporting unit may not be recoverable. The qualitative assessment was primarily due to the customer contracts held by Optilan (UK) Limited and the associated revenue projections by the UK subsidiary that is subject to the potential winding up. As such, the Company compared the fair value of the reporting unit to the carrying amounts and recorded an impairment loss of $ 6,925,137 356,260 6,568,877 0
Property and Equipment	Property and Equipment Property and equipment are carried at historical cost less accumulated depreciation. Depreciation is based on the estimated service lives of the depreciable assets and is calculated using the straight-line method. Expenditures that increase the value or productive capacity of assets are capitalized. Fully depreciated assets are retained in the property and equipment, and accumulated depreciation accounts until they are removed from service. When property and equipment are retired, sold or otherwise disposed of, the asset’s carrying amount and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. Repairs and maintenance are expensed as incurred. The estimated useful lives of property and equipment are generally as follows: Schedule of estimated useful lives Years Office furniture and fixtures 4 Plant and equipment 4-8 Leasehold Improvements 10 Motor vehicles 3
Revenue Recognition	Revenue Recognition The Company’s revenues are generated primarily from the sale of our services, which consist primarily of advanced technology solutions for integrated communications and security systems, as well as habitat management. The Company’s sales of products are primarily generated from our TJM subsidiaries. Sales of products and services are separate from one another. At contract inception, we assess the goods and services promised in the contract with customers and identify a performance obligation for each. To determine the performance obligation, we consider all products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the amount of consideration expected to be received in exchange for transferring goods and services. We recognize service revenues as the performance obligations are met, which is generally as milestones are satisfied over time. We generally recognize product revenues at the time of shipment, provided that all other revenue recognition criteria have been met. The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, we perform the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy a performance obligation. The five-step model is applied to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services transferred to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize revenue in the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied. The Company considers each individual sale of service contract to be its own performance obligation. Services in the contract are highly interdependent and interrelated, and the successful completion of each milestone is necessary for the overall success of the contract. Therefore, each milestone is not separately identifiable from other promises in the contract, and not distinct and ultimately not individual performance obligations. The Company records revenue over time using the input measure as it is the most faithful depiction of an entity’s performance because it directly measures the value of the goods and services transferred to the customer. The Company utilizes the Right to Invoice for these contracts, as the pricing structure is based on various milestones that are specified in the contract. These milestones include Construction Phase Plan, Start of the construction phase, installation phase, site surveys, fiber splicing, recoveries, and closeouts. There are specified payments associated with these milestones in the contract, and the value allocated is commensurate with work done. In the event that there are advances such as upfront retainers and not based on the value, those are recorded as contract liabilities.
Cost of Revenues	Cost of Revenues Cost of revenues consists primarily of materials and overhead costs incurred internally and amounts incurred to contract manufacturers to produce our products, airtime and other implementation costs incurred to install our products and train customer personnel, and customer service and third-party original equipment manufacturer costs to provide continuing support to our customers. Cost of revenues also includes direct labor attributable to revenue service arrangements.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents. The Company has not experienced any losses related to its cash and does not believe that it is subject to unusual credit risk beyond the normal credit risk associated with commercial banking relationships.
Leases	Leases The Company accounts for its leases under ASC 842, Leases In calculating the right of use asset and lease liability, the Company has elected to combine lease and non-lease components. The Company excludes short-term leases having initial terms of 12 months or less from the new guidance as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC 820, Fair Value Measurements and Disclosures. Level 1 – Quoted prices are available in active markets for identical assets or liabilities as of the reporting date. Active markets are those in which transactions for the asset or liability occur in sufficient frequency and volume to provide pricing information on an ongoing basis. Level 1 primarily consists of financial instruments such as exchange-traded derivatives, marketable securities and listed equities. Level 2 – Pricing inputs are other than quoted prices in active markets included in level 1, which are either directly or indirectly observable as of the reported date and includes those financial instruments that are valued using models or other valuation methodologies. These models are primarily industry-standard models that consider various assumptions, including quoted forward prices for commodities, time value, volatility factors, and current market and contractual prices for the underlying instruments, as well as other relevant economic measures. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data or are supported by observable levels at which transactions are executed in the marketplace. Instruments in this category generally include non-exchange-traded derivatives such as commodity swaps, interest rate swaps, options and collars. Level 3 – Pricing inputs include significant inputs that are generally less observable from objective sources. These inputs may be used with internally developed methodologies that result in management’s best estimate of fair value. The Company’s derivative liability is a Level 3 liability measured at fair value on a recurring basis. See Note 10.
Non-controlling Interests	Non-controlling Interests Non-controlling interests are classified as a separate component of equity in the Company's consolidated balance sheets and statements of changes in stockholders’ equity. Net income (loss) and comprehensive income (loss) attributable to non-controlling interests are reflected separately from consolidated net income (loss) and comprehensive income (loss) in the consolidated statements of comprehensive income (loss) and statements of changes in stockholders’ equity. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests. In addition, when a subsidiary is deconsolidated, any retained non-controlling equity investment in the former subsidiary will be initially measured at fair value and the difference between the carrying value and fair value of the retained interest will be recorded as a gain or loss. The Company has non-controlling interests via its subsidiaries TerraData, Remote Intelligence and Wildlife Specialists. During the nine months ended September 30, 2023 and 2022, the Company recorded a loss of $ 821,977 255,835
Comprehensive Loss	Comprehensive Loss Comprehensive loss includes net loss as well as other changes in stockholders’ equity that result from transactions and economic events other than those with stockholders. During the nine months ended September 30, 2023 and 2022, the Company’s only element of other comprehensive loss was foreign currency translation.
Loss Per Common Share	Loss Per Common Share The Company accounts for earnings per share pursuant to ASC 260, Earnings per Share Schedule of antidilutive shares September 30, 2023 2022 Convertible notes 302,912,039 87,775,272 Series D preferred stock 176,470 176,470 303,088,509 87,951,742
Recent Accounting Pronouncements	Recent Accounting Pronouncements In April 2019, the FASB issued ASU 2019-04, Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging Financial Instruments, Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief On January 1, 2023, the Company adopted ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASC 326). Management does not believe that any other recently issued, but not yet effective, accounting standards could have a material effect on the accompanying financial statements. As new accounting pronouncements are issued, the Company will adopt those that are applicable.

SIGNIFICANT ACCOUNTING POLICI_3

SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Schedule of estimated useful lives	Schedule of estimated useful lives Years Office furniture and fixtures 4 Plant and equipment 4-8 Leasehold Improvements 10 Motor vehicles 3
Schedule of antidilutive shares	Schedule of antidilutive shares September 30, 2023 2022 Convertible notes 302,912,039 87,775,272 Series D preferred stock 176,470 176,470 303,088,509 87,951,742

REVENUE (Tables)

REVENUE (Tables)	9 Months Ended
	Sep. 30, 2023
Revenue from Contract with Customer [Abstract]
Schedule of timing of revenue recognition	Schedule of timing of revenue recognition Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Services and products transferred at a point in time $ 32,168 $ 463,295 $ 796,716 $ 2,552,462 Services and products transferred over time 49,903 967,809 1,235,957 5,332,018 Total revenue $ 82,071 $ 1,431,104 $ 2,032,673 $ 7,884,480
Schedule of revenue by source	Schedule of revenue by source Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 Products $ 71,886 $ 136,534 $ 329,400 $ 1,246,610 Services 10,185 1,294,570 1,703,273 6,637,870 Total revenue $ 82,071 $ 1,431,104 $ 2,032,673 $ 7,884,480
Schedule of revenue by geographic destination	Schedule of revenue by geographic destination Three Months Ended Nine Months Ended September 30, September 30, 2023 2022 2023 2022 North America $ 74,586 $ 590,028 $ 449,238 $ 1,124,462 United Kingdom 7,485 – 1,397,152 – Rest of world – 841,076 186,283 6,760,018 Total revenue $ 82,071 $ 1,431,104 $ 2,032,673 $ 7,884,480

ACCOUNTS RECEIVABLE (Tables)

ACCOUNTS RECEIVABLE (Tables)	9 Months Ended
	Sep. 30, 2023
Receivables [Abstract]
Schedule of accounts receivable	Schedule of accounts receivable September 30, December 31, 2023 2022 Accounts receivable $ 96,287 $ 6,273,276 Less: Allowance for doubtful accounts – (3,320,983 ) Accounts receivable, net $ 96,287 $ 2,952,293

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
Schedule of property and equipment	Schedule of property and equipment September 30, December 31, 2023 2022 Property and equipment $ 1,300,521 $ 3,942,421 Leasehold improvements 46,934 46,934 Property and equipment at cost 1,347,455 3,989,355 Less - accumulated depreciation (472,282 ) (2,055,484 ) Property and equipment, net $ 875,173 $ 1,933,871

GOODWILL AND OTHER INTANGIBLE_2

GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of changes in carrying amount of goodwill	Schedule of changes in carrying amount of goodwill Goodwill Balances at December 31, 2022 $ 6,462,153 Impairment of goodwill pertaining to Optilan (6,568,877 ) Foreign exchange translation 106,724 Balances at September 30, 2023 $ –
Schedule of patents	Schedule of patents September 30, December 31, 2023 2022 Patents $ 904,269 $ 904,269 Less: accumulated amortization (674,665 ) (636,394 ) Patents, net $ 229,604 $ 267,875

ACCOUNTS PAYABLE AND ACCRUED _2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Schedule of accounts payable and accrued expenses	Schedule of accounts payable and accrued expenses September 30, December 31, 2023 2022 Accounts payable $ 14,108,937 $ 8,677,648 Accrued liabilities 1,519,043 2,058,725 Total accounts payable and accrued expenses $ 15,627,980 $ 10,736,373

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of convertible notes	Schedule of convertible notes September 30, 2023 December 31, 2022 Principal outstanding $ 382,616 $ 378,263 Less: unamortized debt discount (48,125 ) – Convertible notes, net $ 334,491 $ 378,263
Schedule of loans payable	Schedule of loans payable September 30, December 31, 2023 2022 RI - line of credit $ 99,971 $ 99,971 RI - Short-term loans 41,279 43,899 WS - line of credit 200,000 200,000 WS- Short-term loans 126,817 128,830 Loan payable, current $ 468,067 $ 472,700 RI - SBA EIDL $ 102,597 $ 102,597 RI - long-term loans 84,661 86,041 WS - SBA EIDL 26,307 26,307 WS - long-term loans 92,446 113,564 Loan payable, non-current $ 306,011 $ 328,508

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 30, 2023
Leases
Schedule of operating leases	Schedule of operating leases September 30, December 31, Operating leases 2023 2022 Assets ROU operating lease assets $ 1,020,585 $ 2,724,226 Liabilities Current portion of operating lease 213,821 512,373 Operating lease, net of current portion 907,124 2,547,524 Total operating lease liabilities $ 1,120,945 $ 3,059,897
Schedule of weighted average remaining lease term and weighted average discount rate	Schedule of weighted average remaining lease term and weighted average discount rate September 30, December 31, Operating leases 2023 2022 Weighted average remaining lease term (years) 7.75 8.25 Weighted average discount rate 6.00 6.00

STOCKHOLDERS' EQUITY (DEFICIT)

STOCKHOLDERS' EQUITY (DEFICIT) (Tables)	9 Months Ended
	Sep. 30, 2023
STOCKHOLDERS' DEFICIT:
Schedule of equity financing agreement	Schedule of equity financing agreement Date of Put Number of Common Shares Issued Total Proceeds, Net of Discounts Effective Price per Share Net Proceeds 1/12/2023 64,130,435 $ 400,000 $0.006237 $ 370,975 1/17/2023 11,441,647 100,000 $0.008740 100,000 1/24/2023 77,733,861 400,000 $0.005146 370,975 2/3/2023 61,173,706 300,000 $0.004904 277,975 2/17/2023 75,447,571 300,000 $0.003976 277,975 3/1/2023 83,113,044 324,000 $0.003898 300,295 3/16/2023 93,165,852 254,232 $0.002729 235,410 3/30/2023 65,465,384 166,903 $0.002549 154,195 4/11/2023 67,462,162 203,553 $0.003017 188,280 4/28/2023 91,796,875 235,000 $0.002560 208,550 6/26/2023 44,583,334 214,000 $0.004800 141,020 7/3/2023 51,442,308 274,058 $0.004200 257,020 7/10/2023 28,593,750 91,500 $0.003200 85,094 9/5/2023 100,000,000 100,000 $0.001000 100,000 915,549,929 $ 3,363,246 $ 3,067,764

BASIS OF PRESENTATION AND SUM_2

BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Bad debt expense	$ 11,506	$ 0	$ 2,433,963	$ 0
Impairment of goodwill	0	$ 0	6,925,137	$ 0
Optilan (UK) [Member]
Bad debt expense			2,422,457
Impairment of goodwill			6,925,137
Goodwill and intangible assets	$ 0		0
Optilan (UK) [Member] | Indefinite Lived Asset [Member]
Impairment of goodwill			356,260
Optilan (UK) [Member] | Goodwill [Member]
Impairment of goodwill			$ 6,568,877

SIGNIFICANT ACCOUNTING POLICI_4

SIGNIFICANT ACCOUNTING POLICIES (Details - Estimated useful lives)	9 Months Ended
	Sep. 30, 2023
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	4
Plant And Equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	4-8
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	10
Motor Vehicles [Member]
Property, Plant and Equipment [Line Items]
Estimated useful life	3

SIGNIFICANT ACCOUNTING POLICI_5

SIGNIFICANT ACCOUNTING POLICIES (Details - Antidilutive shares) - shares	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	303,088,509	87,951,742
Convertible Notes [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	302,912,039	87,775,272
Series D Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive shares	176,470	176,470

SIGNIFICANT ACCOUNTING POLICI_6

SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)	3 Months Ended		9 Months Ended
	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Sep. 30, 2023 USD ($)	Sep. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)
Allowance for doubtful accounts	$ 0		$ 0		$ 3,320,983
Retainage receivable	0		0		$ 824,777
Impairment expense	0	$ 0	6,925,137	$ 0
Net loss attributable to non-controlling interests	11,284	$ (92,571)	821,977	$ 255,835
Optilan (UK) [Member]
Impairment expense			6,925,137
Goodwill and intangible assets	$ 0		0
Optilan (UK) [Member] | Indefinite Lived Asset [Member]
Impairment expense			356,260
Optilan (UK) [Member] | Goodwill [Member]
Impairment expense			$ 6,568,877
United Kingdom, Pounds
Foreign currency translation rates	1.2197	1.113030	1.2197	1.113030
Foreign currency translation rates			1.2384	1.259161
Canada, Dollars
Foreign currency translation rates	1.3586	1.3751	1.3586	1.3751

LIQUIDITY AND GOING CONCERN (De

LIQUIDITY AND GOING CONCERN (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Profit loss	$ 998,576	$ 4,118,100	$ 14,799,264	$ 8,805,668	$ 4,185,572	$ 5,384,270	$ 19,915,940	$ 18,375,506
Net cash used in operating activities							4,066,096	$ 19,456,701
Working capital	18,527,365						18,527,365
Accumulated deficit	65,649,298						65,649,298		$ 46,555,334
Cash	$ 64,892						$ 64,892

REVENUE (Details - Timing of re

REVENUE (Details - Timing of revenue recognition) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 82,071	$ 1,431,104	$ 2,032,673	$ 7,884,480
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Total revenue	32,168	463,295	796,716	2,552,462
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Total revenue	$ 49,903	$ 967,809	$ 1,235,957	$ 5,332,018

REVENUE (Details - Revenue by s

REVENUE (Details - Revenue by source) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 82,071	$ 1,431,104	$ 2,032,673	$ 7,884,480
Product [Member]
Disaggregation of Revenue [Line Items]
Total revenue	71,886	136,534	329,400	1,246,610
Service [Member]
Disaggregation of Revenue [Line Items]
Total revenue	$ 10,185	$ 1,294,570	$ 1,703,273	$ 6,637,870

REVENUE (Details - Revenue by g

REVENUE (Details - Revenue by geographic destination) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 82,071	$ 1,431,104	$ 2,032,673	$ 7,884,480
North America [Member]
Disaggregation of Revenue [Line Items]
Total revenue	74,586	590,028	449,238	1,124,462
UNITED KINGDOM
Disaggregation of Revenue [Line Items]
Total revenue	7,485	0	1,397,152	0
Rest Of World [Member]
Disaggregation of Revenue [Line Items]
Total revenue	$ 0	$ 841,076	$ 186,283	$ 6,760,018

ACCOUNTS RECEIVABLE (Details)

ACCOUNTS RECEIVABLE (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Receivables [Abstract]
Accounts receivable	$ 96,287	$ 6,273,276
Less: Allowance for doubtful accounts	0	(3,320,983)
Accounts receivable, net	$ 96,287	$ 2,952,293

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and equipment at cost	$ 1,347,455	$ 3,989,355
Less - accumulated depreciation	(472,282)	(2,055,484)
Property and equipment, net	875,173	1,933,871
Property, Plant and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment at cost	1,300,521	3,942,421
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and equipment at cost	$ 46,934	$ 46,934

GOODWILL AND OTHER INTANGIBLE_3

GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Goodwill)	9 Months Ended
	Sep. 30, 2023 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill at beginning	$ 6,462,153
Impairment of goodwill pertaining to Optilan	(6,568,877)
Foreign exchange translation	106,724
Goodwill at ending	$ 0

GOODWILL AND OTHER INTANGIBLE_4

GOODWILL AND OTHER INTANGIBLE ASSETS (Details - Patents) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Patents	$ 904,269	$ 904,269
Less: accumulated amortization	(674,665)	(636,394)
Patents, net	$ 229,604	$ 267,875

GOODWILL AND OTHER INTANGIBLE_5

GOODWILL AND OTHER INTANGIBLE ASSETS (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
	Mar. 31, 2023	Sep. 30, 2023	Sep. 30, 2022	Jan. 02, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Amortization of patent		$ 34,225	$ 38,271
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Amortization of patent		38,271	$ 38,271
Optilan Liquidation [Member]
Finite-Lived Intangible Assets [Line Items]
Impairment of trade value	$ 356,260
Optilan Liquidation [Member] | Trade Name [Member]
Finite-Lived Intangible Assets [Line Items]
Carrying value of intangible assets		$ 0			$ 390,330
Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible asset estimated useful life				25 years
Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangible asset estimated useful life				10 years

JOINT VENTURE (Details Narrativ

JOINT VENTURE (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Sep. 09, 2022
Schedule of Equity Method Investments [Line Items]
Contributed joint venture			$ 113,124	$ 0
Loss on equity investment	$ 20,764	$ 0	$ 159,849	$ 0
Neural Signals Inc [Member]
Schedule of Equity Method Investments [Line Items]
Ownership percentage					50%

ACCOUNTS PAYABLE AND ACCRUED _3

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts payable	$ 14,108,937	$ 8,677,648
Accrued liabilities	1,519,043	2,058,725
Total accounts payable and accrued expenses	$ 15,627,980	$ 10,736,373

DEBT (Details - Convertible deb

DEBT (Details - Convertible debt) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Principal outstanding	$ 382,616	$ 378,263
Less: unamortized debt discount	(48,125)
Convertible notes, net	$ 334,491	$ 378,263

DEBT (Details - Loans payable)

DEBT (Details - Loans payable) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Loan payable, current	$ 468,067	$ 472,700
Loan payable, non-current	306,011	328,508
R I Line Of Credit [Member]
Debt Instrument [Line Items]
Loan payable, current	99,971	99,971
R I Short Term Loans [Member]
Debt Instrument [Line Items]
Loan payable, current	41,279	43,899
W S Line Of Credit [Member]
Debt Instrument [Line Items]
Loan payable, current	200,000	200,000
W S Short Term Loans [Member]
Debt Instrument [Line Items]
Loan payable, current	126,817	128,830
R I S B A E I D L [Member]
Debt Instrument [Line Items]
Loan payable, non-current	102,597	102,597
R I Long Term Loans [Member]
Debt Instrument [Line Items]
Loan payable, non-current	84,661	86,041
W S S B A E I D L [Member]
Debt Instrument [Line Items]
Loan payable, non-current	26,307	26,307
W S Long Term Loans [Member]
Debt Instrument [Line Items]
Loan payable, non-current	$ 92,446	$ 113,564

DEBT (Details Narrative)

DEBT (Details Narrative) - USD ($)			9 Months Ended
	Aug. 07, 2023	Jul. 14, 2021	Sep. 30, 2023	Sep. 30, 2022	Sep. 29, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Convertible Notes Payable, Current			$ 334,491			$ 378,263
Derivative Liability, Current			597,318			306,467
Convertible note	$ 57,750
Interest rate	10%
Debt conversion converted instrument discount rate	39%
G S Spa Note [Member]
Debt Instrument [Line Items]
Debt face amount		$ 2,000,000
Maturity date		Jul. 14, 2022
Debt interest rate		6%
Debt outstanding			2,000,000			$ 2,000,000
Sept Convertible Note [Member]
Debt Instrument [Line Items]
Debt face amount					$ 57,750
Convertible Debt [Member]
Debt Instrument [Line Items]
Amortization of debt discount			$ 9,625	$ 0

SECURED DEBENTURE (Details Narr

SECURED DEBENTURE (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Debt Disclosure [Abstract]
Interest expense	$ 19,401	$ 36,307
Debenture liability	$ 1,099,250		$ 1,090,827

LEASES (Details - Balance sheet

LEASES (Details - Balance sheet) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Assets
ROU operating lease assets	$ 1,020,585	$ 2,724,226
Liabilities
Current portion of operating lease	213,821	512,373
Operating lease, net of current portion	907,124	2,547,524
Total operating lease liabilities	$ 1,120,945	$ 3,059,897

LEASES (Details - Other Informa

LEASES (Details - Other Information)	Sep. 30, 2023	Dec. 31, 2022
Leases
Weighted average remaining lease term (years)	7 years 9 months	8 years 3 months
Weighted average discount rate	6%	6%

LEASES (Details Narrative)

LEASES (Details Narrative) - USD ($)	Mar. 09, 2022	Oct. 20, 2021	Aug. 31, 2021	May 27, 2021	Jan. 12, 2021
Leases
Annual rent	$ 81,000	$ 200,000	$ 192,000	$ 85,000	$ 50,000

STOCKHOLDERS' EQUITY (DEFICIT_2

STOCKHOLDERS' EQUITY (DEFICIT) (Details) - USD ($)															9 Months Ended
	Sep. 05, 2023	Jul. 10, 2023	Jul. 03, 2023	Jun. 26, 2023	Apr. 28, 2023	Apr. 11, 2023	Mar. 30, 2023	Mar. 16, 2023	Mar. 01, 2023	Feb. 17, 2023	Feb. 03, 2023	Jan. 24, 2023	Jan. 17, 2023	Jan. 12, 2023	Sep. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares sold															915,549,929
Total proceeds, net of discounts															$ 3,363,246
Net Proceeds															$ 3,067,764
Equity Financing Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of shares sold	100,000,000	28,593,750	51,442,308	44,583,334	91,796,875	67,462,162	65,465,384	93,165,852	83,113,044	75,447,571	61,173,706	77,733,861	11,441,647	64,130,435
Total proceeds, net of discounts	$ 100,000	$ 91,500	$ 274,058	$ 214,000	$ 235,000	$ 203,553	$ 166,903	$ 254,232	$ 324,000	$ 300,000	$ 300,000	$ 400,000	$ 100,000	$ 400,000
Effective price per share	$ 0.001000	$ 0.003200	$ 0.004200	$ 0.004800	$ 0.002560	$ 0.003017	$ 0.002549	$ 0.002729	$ 0.003898	$ 0.003976	$ 0.004904	$ 0.005146	$ 0.008740	$ 0.006237
Net Proceeds	$ 100,000	$ 85,094	$ 257,020	$ 141,020	$ 208,550	$ 188,280	$ 154,195	$ 235,410	$ 300,295	$ 277,975	$ 277,975	$ 370,975	$ 100,000	$ 370,975

STOCKHOLDERS' EQUITY (DEFICIT_3

STOCKHOLDERS' EQUITY (DEFICIT) (Details Narrative) - USD ($)	1 Months Ended
	Jan. 31, 2023	Sep. 30, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Preferred stock, shares issued		88,335	88,335
Preferred stock, shares outstanding		88,335	88,335
Common stock, shares authorized		20,000,000,000	20,000,000,000
Common stock par value		$ 0.0001	$ 0.0001
Common stock, shares issued		7,639,945,289	6,427,395,360
Common stock, shares outstanding		7,639,845,289	6,427,295,360
Stock Issued For Settlement Of Dispute [Member]
Class of Stock [Line Items]
Number of shares issued other	297,000,000
Number of value issued other	$ 1,989,900
Share price		$ 0.0067
Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized		2,000,000	2,000,000
Preferred stock, par value		$ 0.01	$ 0.01

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)				9 Months Ended		12 Months Ended
	Mar. 09, 2023	Feb. 07, 2023	Oct. 12, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Purchase price				$ 1,500,000		$ 1,500,000
Aggregate principal amount	$ 167,894	$ 167,894
Due from related party				948,362		318,025
Purchase Agreement [Member]
Purchase price			$ 1,500,000
Purchase Agreement [Member] | Common Class B [Member]
Stock purchased, shares			2,623,120
Purchase Agreement [Member] | Private Placement Warrants [Member]
Warrants purchased, shares			4,298,496
Remote Intelligence [Member]
Loans Payable				226,247		226,247
Wildlife Specialists [Member]
Loans Payable				135,500		135,500
S P A C [Member]
Loans Payable				1,612,565		$ 1,049,248
Optilan [Member]
Noninterest expense directors fees				$ 120,000	$ 0